Microbiota Diversity in Non-Small Cell Lung Cancer Gut and Mouth Cavity Microbiota Diversity in Non-Small Cell Lung Cancer Patients.

Autor:	Brisudová A; 1Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Bielniková-Kryštofová H; 2Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.; 3Faculty of Medicine University of Ostrava, Ostrava, Czech Republic., Motyka O; 4Faculty of Mining and Geology, VŠB - Technical University of Ostrava, Ostrava, Czech Republic.; 5Nanotechnology Centre, CEET, VŠB - Technical University of Ostrava, Ostrava, Czech Republic., Fritzová D; 1Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Katuchová V; 1Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Ponikelská N; 2Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.; 3Faculty of Medicine University of Ostrava, Ostrava, Czech Republic., Skanderová D; 1Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Raclavský V; 6Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Michálek J; 1Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Mitták M; 3Faculty of Medicine University of Ostrava, Ostrava, Czech Republic.; 7Department of Surgical Studies, University Hospital Ostrava, Ostrava, Czech Republic., Švecová P; 8Department of Respiratory Diseases, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Jakubec P; 8Department of Respiratory Diseases, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Rozsivalová D; 8Department of Respiratory Diseases, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Szkorupa M; 9Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Klein J; 10Surgical Clinic, Thomas Bat'a Regional Hospital, Prague Czech Republic., Škarda J; 1Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.; 2Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.; 3Faculty of Medicine University of Ostrava, Ostrava, Czech Republic., Kolář Z; 1Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Skopelidou V; 2Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic.; 3Faculty of Medicine University of Ostrava, Ostrava, Czech Republic.
Jazyk:	angličtina
Zdroj:	Polish journal of microbiology [Pol J Microbiol] 2023 Dec 16; Vol. 72 (4), pp. 467-475. Date of Electronic Publication: 2023 Dec 16 (Print Publication: 2023).
DOI:	10.33073/pjm-2023-044
Abstrakt:	Lung malignancies have a substantial impact on cancer incidence and mortality worldwide. Even though many factors involved in the development of the disease are known, many questions remain unanswered. Previous studies suggest that the intestinal microbiota may have a role in developing malignant diseases. According to some findings, the microbiota has proven to be a key modulator of carcinogenic processes and the immune response against cancer cells, potentially influencing the effectiveness of immunotherapy. In our study, we characterized culturable microorganisms associated with non-small cell lung cancer (NSCLC) that can be recovered from rectal swabs and mouthwash. In addition, we also explored differences in the culturable microbiota with two main types of NSCLC - adenocarcinoma (ADC) and squamous cell carcinoma (SCC). With 141 patients included in the study (86 ADC and 55 SCC cases), a significant difference was observed between the two types in seven bacterial species ( Collinsella, Corynebacterium, Klebsiella, Lactobacillus, Neisseria, Rothia , and Streptococcus ), including the site of origin. The relationship between microbial dysbiosis and lung cancer is poorly understood; future research could shed light on the links between gut microbiota and lung cancer development. (© 2023 Aneta Brisudová et al., published by Sciendo.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu